Christiana Amartey
Research Subjects
Christiana Amartey has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Albert Dayor Piersson
York St John University, School of Science, Technology & Health
1 shared publication - Aquel Rene Lopez
Tetteh Quarshie Memorial Hospital, Akuapem-Mampong, Eastern Region
1 shared publication - Klenam Dzefi-Tettey
Department of Radiology, School of Medicine, University of Health and Allied Sciences, Ho, Ghana
1 shared publication - Promise Emmanuel Sefogah
Department of Obstetrics & Gynaecology, University of Ghana Medical School, Ghana
1 shared publication - Sarah Teiko Quartei
Centre for Education, Population Health Research & Innovation, P. O. Box GP 4560, Accra, Greater Accra Region, Ghana
1 shared publication
Latest Publications
- Open Access
Maternal Willingness to Participate in Research Involving Neuroimaging, Biological Sample Collection, and Data Storage: Towards a Multicentre Neurodevelopmental Research in a low-resource setting
Background: Maternal participation in neurodevelopmental research involving neuroimaging and diverse biological samples is essential for understanding prenatal influences on early brain development, yet willingness in low-resource settings remains underexplored. Method: We surveyed 300 mothers using a structured questionnaire to assess willingness to undergo brain health testing (with a focus on electroencephalography [EEG] and brain magnetic resonance imaging [MRI]), provide biological samples (blood, stool, urine, breast milk, placenta, amniotic fluid, vaginal/nasal fluid, saliva, tears), and consent to 10-year storage. Responses were analysed to examine associations between maternal sociodemographic factors and willingness to consent for each research component. Results: Ninety-two percent of participants expressed willingness for brain health testing, including ∼82% and ∼88% interest in EEG and MRI, respectively, even for untreatable conditions. Self-reported histories of foetal defects (5.3%) and birth defects (7.3%) were notably low. Biospecimen acceptance was highest (>95%) for routine samples (blood, stool, urine) but significantly low for sensitive specimens (breast milk, placenta, amniotic fluid: 51–55%) including (vaginal fluid, saliva, tears: 16–47%). Higher levels of maternal education consistently predicted consent across modalities, while being in a relationship increased willingness for stool, urine, placenta, amniotic fluid, MRI, and EEG. Low income reduced uptake for placenta, amniotic fluid, MRI, and EEG. Only 48% consented to 10-year storage of images and samples for future research. Conclusion: This study demonstrates high maternal willingness for neurodevelopmental research involving brain health testing and routine biospecimens in a low-resource setting. The findings highlight the feasibility of such protocols in a low-resource setting while exposing persistent inequities that risk underrepresenting disadvantaged mothers in maternal-child brain research. Contextually tailored consent models and capacity-building initiatives will be essential to ensure equitable, sustainable engagement across diverse LMIC populations.
Open AccessMaternal Willingness to Participate in Research Involving Neuroimaging, Biological Sample Collection, and Data Storage: Towards a Multicentre Neurodevelopmental Research in a low-resource setting
Background: Maternal participation in neurodevelopmental research involving neuroimaging and diverse biological samples is essential for understanding prenatal influences on early brain development, yet willingness in low-resource settings remains underexplored. Method: We surveyed 300 mothers using a structured questionnaire to assess willingness to undergo brain health testing (with a focus on electroencephalography [EEG] and brain magnetic resonance imaging [MRI]), provide biological samples (blood, stool, urine, breast milk, placenta, amniotic fluid, vaginal/nasal fluid, saliva, tears), and consent to 10-year storage. Responses were analysed to examine associations between maternal sociodemographic factors and willingness to consent for each research component. Results: Ninety-two percent of participants expressed willingness for brain health testing, including ∼82% and ∼88% interest in EEG and MRI, respectively, even for untreatable conditions. Self-reported histories of foetal defects (5.3%) and birth defects (7.3%) were notably low. Biospecimen acceptance was highest (>95%) for routine samples (blood, stool, urine) but significantly low for sensitive specimens (breast milk, placenta, amniotic fluid: 51–55%) including (vaginal fluid, saliva, tears: 16–47%). Higher levels of maternal education consistently predicted consent across modalities, while being in a relationship increased willingness for stool, urine, placenta, amniotic fluid, MRI, and EEG. Low income reduced uptake for placenta, amniotic fluid, MRI, and EEG. Only 48% consented to 10-year storage of images and samples for future research. Conclusion: This study demonstrates high maternal willingness for neurodevelopmental research involving brain health testing and routine biospecimens in a low-resource setting. The findings highlight the feasibility of such protocols in a low-resource setting while exposing persistent inequities that risk underrepresenting disadvantaged mothers in maternal-child brain research. Contextually tailored consent models and capacity-building initiatives will be essential to ensure equitable, sustainable engagement across diverse LMIC populations.